medical device reporting News
-
Lumendi Reports Successful Enrollment Closure of Its Dilumen Endolumenal Interventional Platform (EIP) Study
A STUDY EVALUATING ENDOSCOPIC PROCEDURE TIME REMOVING COMPLEX COLORECTAL POLYPS SHOWS SUPERIORITY OF DILUMEN OVER CONTROL GROUP. Connecticut-based medical device innovator Lumendi, LLC reports that its 1:1 randomized trial of the DiLumen Endoluminal Interventional Platform (EIP) successfully met the primary endpoint of an IRB-approved 200-patient prospective study. The study ...
By Lumendi Ltd.
-
Early Trial Data Show Promise in Endoscopic Procedure Time Study
A STUDY EVALUATING ENDOSCOPIC PROCEDURE TIME REMOVING COMPLEX COLORECTAL POLYPS SHOWS SUPERIORITY OF LUMENDI’S DILUMEN DEVICE OVER A CONTROL GROUP. Connecticut-based medical device innovator Lumendi LLC reports that its 1:1 randomized trial of the DiLumen Endolumenal Interventional Platform (EIP) successfully met the primary endpoint of an IRB-approved 200-patient prospective study. The ...
By Lumendi Ltd.
-
Lumendi Reports First Incisionless Appendectomy Using Double-Balloon Endolumenal Interventional Platform
Patient reported no post-procedure pain and resumed regular activity day after procedure Connecticut-based medical device innovator Lumendi, LLC reports the first endoscopic appendectomy using its DiLumenTM Endolumenal Interventional Platform (EIP). A patient underwent the purely endoscopic endolumenal appendectomy to remove a lesion previously identified at the appendiceal orifice. ...
By Lumendi Ltd.
-
Heartbeat Medical appoints Michael Erdtmann as Chief Commercial Officer
Heartbeat Medical, a leading provider of digital medical devices in the field of Patient-Reported Outcomes (PROs), announced the appointment of Michael Erdtmann as Chief Commercial Officer. As part of the management team, Michael Erdtmann will be responsible for driving the growing new business as well as deepening existing partnerships and providing a bridge between the Medical Devices and Life ...
-
Silver Bullet Therapeutics Reports Results of OrthoFuzIon Antimicrobial Bone Screw Testing Against the Top Six CDC Antibiotic Resistant “Superbugs”
Silver Bullet Therapeutics, Inc., a privately held medical device company that has developed an antimicrobial technology for implantable medical devices such as orthopedic bone screws, reported today the results of a study testing the “Time Kill” and “Adherence” effectiveness of its CE-marked OrthoFuzIon® Antimicrobial Bone Screw against the Top Six CDC ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you